Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”
We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Qorvo ...
Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...
Becker's Hospital Review2d
Bristol Myers Squibb to reduce costs by $2B
Bristol Myers Squibb will cut $2 billion in costs by the end of 2027, a move aimed at long-term growth as the company prepares for patent expirations on key treatments, CNBC reported Feb. 6.